AIM
HQL

Arcadia Investment Management’s abrdn Life Sciences Investors HQL Stock Holding History

Arcadia Investment Management’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-415
Closed -$7K – 380
2016
Q2 		$7K Hold
415
– – ﹤0.01% 414
2016
Q1 		$7K Hold
415
– – ﹤0.01% 271
2015
Q4 		$10K Buy
+415
New +$10.3K ﹤0.01% 258

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Arcadia Investment Management's HQL Position: Q3 2016 in Review

Arcadia Investment Management sold out of abrdn Life Sciences Investors (HQL) in Q3 2016, closing a stake of 415 shares — an estimated $7K sold.

Arcadia Investment Management first reported a position in HQL in Q4 2015 and held it in 3 quarters. The position peaked at $10K in Q4 2015. 45 funds tracked by Wall St. Rank hold HQL as of Q3 2016.

  • Arcadia Investment Management reported no remaining abrdn Life Sciences Investors position as of Q3 2016 after selling out during the quarter.
  • Arcadia Investment Management sold 415 abrdn Life Sciences Investors shares in Q3 2016, an estimated $7K.
  • Arcadia Investment Management first reported a position in abrdn Life Sciences Investors in Q4 2015 and held it in 3 quarters.
  • Arcadia Investment Management's abrdn Life Sciences Investors position peaked at $10K in Q4 2015.
  • 45 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2016.

Based on Arcadia Investment Management's 13F filing for Q3 2016, filed 26 Oct 2016.